7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hormones and Decision Making testosterone propionate, 0.5% cholorbutanol, saline - Dyssocial Behavior | Phase 4 | Completed | University of Texas at Austin | 30 | 2015-03-01 | 2021-04-29 |
| Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder Fluoxetine, DBT, Citalopram - Borderline Personality Disorder, Suicide | Phase 4 | Completed | New York State Psychiatric Institute | 84 | 2009-03-01 | 2017-08-18 |
| Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder Lamotrigine, Placebo - Borderline Personality Disorder | Phase 4 | Completed | Mclean Hospital | 28 | 2004-12-01 | 2008-03-12 |
| Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder risperidone - Borderline Personality Disorder | Phase 4 | Completed | University of Alabama at Birmingham | 20 | 2003-07-01 | 2021-06-10 |
| Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder Fluoxetine, Dialectical Behavior Therapy, Supportive psychotherapy - Borderline Personality Disorder | Phase 4 | Completed | New York State Psychiatric Institute | 91 | 2001-03-01 | 2024-01-05 |
| Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) Psychosocial treatment, Anti-ADHD medication, Assessment-and-Referral - Attention Deficit Disorder With Hyperactivity, Substance-related Disorders | Phase 4 | Completed | NYU Langone Health | 1998-09-01 | 2015-09-29 | |
| Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder Interpersonal Social Rhythm Therapy (IPSRT) - Bipolar I Disorder, Borderline Personality Disorder | Phase 4 | Completed | University of Pittsburgh | 13 | 1997-08-01 | 2013-06-25 |
Borderline Personality Disorder (5) · Antisocial Personality Disorder (2) · Self-Injurious Behavior (2) · Suicide (2) · Attention Deficit Disorder with Hyperactivity (1) · Substance-Related Disorders (1)
Mental Disorders (7) · Behavior (2) · Behavioral Symptoms (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Chemically-Induced Disorders (1) · Neurodevelopmental Disorders (1)
Fluoxetine (2) · Citalopram (1) · Dialectical Behavior Therapy (1) · Lamotrigine (1) · Risperidone (1) · Sodium Chloride (1) · Testosterone Propionate (1)
New York State Psychiatric Institute (2) · Mclean Hospital (1) · NYU Langone Health (1) · University of Alabama at Birmingham (1) · University of Pittsburgh (1) · University of Texas at Austin (1)
United States (6)
Barbara H. Stanley, PhD (1) · Barbara Stanley, PhD (1) · C. Keith Conners (1) · Celia T. Huston, PhD (1) · D. Bradford Reich, M.D. (1) · Ellen Frank (1) · Howard B. Abikoff, PhD (1) · James M. Swanson, PhD (1) · Laurence L. Greenhill, MD (1) · Robert A Josephs, PhD (1) · Stephen P. Hinshaw, PhD (1) · William E. Pelham, PhD (1)
PMID 33884617, PMID 10591283, PMID 10591284, PMID 10637676, PMID 10637677, PMID 11104313, PMID 11104315, PMID 11104317, PMID 11211363, PMID 11211364, PMID 11211365, PMID 11211366, PMID 11211367, PMID 11294072, PMID 12014781, PMID 12108764, PMID 12795577, PMID 12880507, PMID 14998110, PMID 15060225, PMID 15677282, PMID 16135621, PMID 16671928, PMID 16881772, PMID 17053977, PMID 17667478, PMID 17667479, PMID 17667480, PMID 17667481, PMID 17710545, PMID 18573923, PMID 18573924, PMID 19307987, PMID 19318991, PMID 20390813, PMID 20883582, PMID 23452682, PMID 23834228, PMID 25524791, PMID 28913744, PMID 29050505, PMID 30388029, PMID 31120201, PMID 31421233, PMID 31445873, PMID 32368793, PMID 34384227, PMID 36375174, PMID 39431909, PMID 7665456
R01MH061017 (2), U01MH050453 (1)